Foldax is Therapeutic Devices in United States that focus on tricuspid valve disease business. Founded in 2013. They cover business area such as developer, synthetic heart valve, artificial blood pump support, life polymer technology, order, diseased heart valve, transcatheter or surgical delivery, a lifetime, anticoagulant drug, their risk, side effect, patient, aortic, mitral, and tricuspid valve disease cost-effective treatment.
2013
( 11 years old in 2024 )
Tricuspid Valve Disease
-
825 North 300 West
Suite Northeast- 500
Salt Lake City, UT 84103
United States
Private
developersynthetic heart valveartificial blood pump supportlife polymer technologyorderdiseased heart valvetranscatheter or surgical deliverya lifetimeanticoagulant drugtheir riskside effectpatientaortic, mitral, and tricuspid valve disease cost-effective treatment
* We use standard office opening hours in near Foldax's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Foldax is Therapeutic Devices business from United States that founded in 2013 (11 years old in 2024), Foldax business is focusing on Tricuspid Valve Disease.
Foldax headquarter office and corporate office address is located in 825 North 300 West Suite Northeast- 500 Salt Lake City, UT 84103 United States.
Foldax was founded in United States.
In 2024, Foldax is currently focus on tricuspid valve disease sector.
Above is snippet of Google Trends for "tricuspid valve disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Foldax, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
